Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    1(33%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    1
    33%
    Phase 4
    2
    67%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    2

    Late Stage

    Phase Distribution3 total trials
    Phase 1Safety & dosage
    1(33.3%)
    Phase 4Post-market surveillance
    2(66.7%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(1)
    Completed(2)

    Detailed Status

    Completed2
    Active, not recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 11 (33.3%)
    Phase 42 (66.7%)

    Trials by Status

    active_not_recruiting133%
    completed267%

    Recent Activity

    1 active trials
    Showing 3 of 3
    active_not_recruitingphase_1

    CHemotherapy And Stool Transplant in PDAC (CHASe-PDAC)

    NCT06393400
    completedphase_4

    Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

    NCT03742232
    completedphase_4

    A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

    NCT00583609

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT06393400Phase 1

    CHemotherapy And Stool Transplant in PDAC (CHASe-PDAC)

    Active Not Recruiting
    NCT03742232Phase 4

    Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

    Completed
    NCT00583609Phase 4

    A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3